25% of the book profits will be automatically donated to Dr. Seyfried's research, as seen on ketoforcancer net. ! This book is a collection of transcripts, and is NOT representative of Dr. Seyfried's original scientific book !It is rather an overview of Dr. Thomas Seyfrieds opinions on cancer, expressed throught Youtube video transcripts, regarding that Cancer is a metabolic disease. It comprises1) Transcripts of his talks and interviews that summarize all his most important points, as well as2) A Presentation by his collegue Dr. Dominic D'Agostiono about the "Press Pulse Strategy" an3) A thriller-like keto origin story by Travis Christofferson and Robb WolffAs this is the extended version for students, doctors and interested citizens, meaning there are 2 more interviews:4. An interview with Dr. Anthony Chaffee, in which especially the health care system in the US is focused on. 5. An in-depth interview with Dr. Petter Attia, that talks especially about the biochemistry and the scientific possibilities regarding this metabolic treatment option. Everything is illustrated with easy to understand images and graphs, as well as the scientific references. Here the description of his work as a professor:Dr. Thomas Seyfried's work in the field of cancer challenges conventional beliefs and addresses the controversial origins of cancer. His research offers innovative solutions for both the management and prevention of cancer, building upon Otto Warburg's theory that cancer fundamentally stems from disruptions in energy metabolism. While Warburg's theory lacked a direct connection to the recognized "hallmarks of cancer, " which led to its discredit, Seyfried's work seeks to rectify this by presenting case studies as compelling evidence that cancer is primarily a metabolic disease. He argues that metabolic approaches are key to effectively managing and preventing cancer. Seyfried's position finds support in a critical evaluation of existing cancer theories. He underscores the relevance of brain cancer case studies, which serve as a proof of principle for metabolic-based strategies in disease management. Importantly, he also highlights the potential applicability of these metabolic solutions to other types of cancer, such as breast and colon cancer, given the shared cellular mutations in energy metabolism that these cancers exhibit.